Literature DB >> 27193224

Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation.

Haipo Yang1, Hiroshi Manya2, Kazuhiro Kobayashi3, Hui Jiao1, Xiaona Fu1, Jiangxi Xiao4, Xiaoqing Li5, Jingmin Wang1, Yuwu Jiang1, Tatsushi Toda3, Tamao Endo2, Xiru Wu1, Hui Xiong1.   

Abstract

Protein O-mannosyltransferase 1 (POMT1) is a glycosyltransferase involved in α-dystroglycan glycosylation. POMT1 mutations cause a wide spectrum of clinical conditions from Walker-Warburg syndrome (WWS), which involves muscle, eye and brain abnormalities, to mild forms of limb-girdle muscular dystrophy with mental retardation. We aimed to elucidate the impact of different POMT1 mutations on the clinical phenotype. We report five Chinese patients with POMT1 mutations: one had a typical clinical manifestation of WWS, and the other four were diagnosed with congenital muscular dystrophy with mental retardation of varying severity. We analyzed the influence of the POMT1 mutations on POMT activity by assaying the patients' muscles and cultured skin fibroblasts. We demonstrated different levels of decreased POMT activity that correlated highly with decreased α-dystroglycan glycosylation. Our results suggest that POMT activity is inversely proportional to clinical severity, and demonstrate that skin fibroblasts can be used for differential diagnosis of patients with α-dystroglycanopathies. We have provided clinical, histological, enzymatic and genetic evidence of POMT1 involvement in five unrelated Chinese patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27193224     DOI: 10.1038/jhg.2016.42

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  23 in total

1.  Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation.

Authors:  Keiko Akasaka-Manya; Hiroshi Manya; Tamao Endo
Journal:  Biochem Biophys Res Commun       Date:  2004-12-03       Impact factor: 3.575

2.  Milder phenotype of congenital muscular dystrophy in a novel POMT1 mutation.

Authors:  Samiah A Al-Zaidy; Berivan Baskin; Cynthia Hawkins; Grace Yoon; Peter N Ray; Jiri Vajsar
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

3.  Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality.

Authors:  Tobias Willer; Belén Prados; Juan Manuel Falcón-Pérez; Ingrid Renner-Müller; Gerhard K H Przemeck; Mark Lommel; Antonio Coloma; M Carmen Valero; Martin Hrabé de Angelis; Widmar Tanner; Eckhard Wolf; Sabine Strahl; Jesús Cruces
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

4.  Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly.

Authors:  Sandrine Vuillaumier-Barrot; Céline Bouchet-Séraphin; Malika Chelbi; Louise Devisme; Samuel Quentin; Steven Gazal; Annie Laquerrière; Catherine Fallet-Bianco; Philippe Loget; Sylvie Odent; Dominique Carles; Anne Bazin; Jacqueline Aziza; Alix Clemenson; Fabien Guimiot; Maryse Bonnière; Sophie Monnot; Christine Bole-Feysot; Jean-Pierre Bernard; Laurence Loeuillet; Marie Gonzales; Koryna Socha; Bernard Grandchamp; Tania Attié-Bitach; Férechté Encha-Razavi; Nathalie Seta
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

Review 5.  Abnormal glycosylation of dystroglycan in human genetic disease.

Authors:  Jane E Hewitt
Journal:  Biochim Biophys Acta       Date:  2009-06-17

6.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.

Authors:  Daniel Beltrán-Valero de Bernabé; Sophie Currier; Alice Steinbrecher; Jacopo Celli; Ellen van Beusekom; Bert van der Zwaag; Hülya Kayserili; Luciano Merlini; David Chitayat; William B Dobyns; Bru Cormand; Ana-Elina Lehesjoki; Jesús Cruces; Thomas Voit; Christopher A Walsh; Hans van Bokhoven; Han G Brunner
Journal:  Am J Hum Genet       Date:  2002-10-04       Impact factor: 11.025

7.  Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies.

Authors:  Hiroshi Manya; Céline Bouchet; Akiko Yanagisawa; Sandrine Vuillaumier-Barrot; Susana Quijano-Roy; Yasushi Suzuki; Svetlana Maugenre; Pascale Richard; Toshiyuki Inazu; Luciano Merlini; Norma B Romero; France Leturcq; Isabelle Bezier; Haluk Topaloglu; Brigitte Estournet; Nathalie Seta; Tamao Endo; Pascale Guicheney
Journal:  Neuromuscul Disord       Date:  2007-09-14       Impact factor: 4.296

8.  Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan.

Authors:  Tony Roscioli; Erik-Jan Kamsteeg; Karen Buysse; Isabelle Maystadt; Jeroen van Reeuwijk; Christa van den Elzen; Ellen van Beusekom; Moniek Riemersma; Rolph Pfundt; Lisenka E L M Vissers; Margit Schraders; Umut Altunoglu; Michael F Buckley; Han G Brunner; Bernard Grisart; Huiqing Zhou; Joris A Veltman; Christian Gilissen; Grazia M S Mancini; Paul Delrée; Michèl A Willemsen; Danijela Petković Ramadža; David Chitayat; Christopher Bennett; Eamonn Sheridan; Els A J Peeters; Gita M B Tan-Sindhunata; Christine E de Die-Smulders; Koenraad Devriendt; Hülya Kayserili; Osama Abd El-Fattah El-Hashash; Derek L Stemple; Dirk J Lefeber; Yung-Yao Lin; Hans van Bokhoven
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

Review 9.  Walker-Warburg syndrome.

Authors:  Jiri Vajsar; Harry Schachter
Journal:  Orphanet J Rare Dis       Date:  2006-08-03       Impact factor: 4.123

10.  Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.

Authors:  Caroline Godfrey; Emma Clement; Rachael Mein; Martin Brockington; Janine Smith; Beril Talim; Volker Straub; Stephanie Robb; Ros Quinlivan; Lucy Feng; Cecilia Jimenez-Mallebrera; Eugenio Mercuri; Adnan Y Manzur; Maria Kinali; Silvia Torelli; Susan C Brown; Caroline A Sewry; Kate Bushby; Haluk Topaloglu; Kathryn North; Stephen Abbs; Francesco Muntoni
Journal:  Brain       Date:  2007-09-18       Impact factor: 13.501

View more
  4 in total

1.  Functional Similarities between the Protein O-Mannosyltransferases Pmt4 from Bakers' Yeast and Human POMT1.

Authors:  Daniela Bausewein; Jakob Engel; Thomas Jank; Maria Schoedl; Sabine Strahl
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

Review 2.  Genetic and Clinical Advances of Congenital Muscular Dystrophy.

Authors:  Xiao-Na Fu; Hui Xiong
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

3.  Structure of the eukaryotic protein O-mannosyltransferase Pmt1-Pmt2 complex.

Authors:  Lin Bai; Amanda Kovach; Qinglong You; Alanna Kenny; Huilin Li
Journal:  Nat Struct Mol Biol       Date:  2019-07-08       Impact factor: 15.369

4.  Clinical long-time course, novel mutations and genotype-phenotype correlation in a cohort of 27 families with POMT1-related disorders.

Authors:  Tobias Geis; Tanja Rödl; Haluk Topaloğlu; Burcu Balci-Hayta; Sophie Hinreiner; Wolfgang Müller-Felber; Benedikt Schoser; Yasmin Mehraein; Angela Hübner; Birgit Zirn; Markus Hoopmann; Heiko Reutter; David Mowat; Gerhard Schuierer; Ulrike Schara; Ute Hehr; Heike Kölbel
Journal:  Orphanet J Rare Dis       Date:  2019-07-16       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.